Loading company…
Zhongke Yiwei develops diagnostic products and services for exosomes.
Founded in 2022 in Suzhou, Zhongke Yiwei develops, produces, and sells exosome diagnostic products and services. Its team has experience in nanoscience, chemistry, biology, medicine, and in vitro diagnostics. In March 2026, it closed a Pre-series A round from Changchun Equity Investment Fund Management to support research and industrialization in precision medicine for oncology and neurodegenerative diseases.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in